BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koulouridi A, Messaritakis I, Gouvas N, Tsiaoussis J, Souglakos J. Immunotherapy in Solid Tumors and Gut Microbiota: The Correlation-A Special Reference to Colorectal Cancer. Cancers (Basel) 2020;13:E43. [PMID: 33375686 DOI: 10.3390/cancers13010043] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Messaritakis I, Koulouridi A, Boukla E, Sfakianaki M, Vogiatzoglou K, Karagianni M, Gouvas N, Tsiaoussis J, Xynos E, Athanasakis E, Mavroudis D, Tzardi M, Souglakos J. Investigation of Microbial Translocation, TLR and VDR Gene Polymorphisms, and Recurrence Risk in Stage III Colorectal Cancer Patients. Cancers (Basel) 2022;14:4407. [PMID: 36139567 DOI: 10.3390/cancers14184407] [Reference Citation Analysis]
2 Liu Q, Sun W, Zhang H. Interaction of Gut Microbiota with Endocrine Homeostasis and Thyroid Cancer. Cancers (Basel) 2022;14:2656. [PMID: 35681636 DOI: 10.3390/cancers14112656] [Reference Citation Analysis]
3 Lin Y, Kong D, Zhang Y. Does the Microbiota Composition Influence the Efficacy of Colorectal Cancer Immunotherapy? Front Oncol 2022;12:852194. [DOI: 10.3389/fonc.2022.852194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Carlsen L, Huntington KE, El-deiry WS. Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers. Cancers 2022;14:1028. [DOI: 10.3390/cancers14041028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
5 Wu M, Bai J, Ma C, Wei J, Du X. The Role of Gut Microbiota in Tumor Immunotherapy. J Immunol Res 2021;2021:5061570. [PMID: 34485534 DOI: 10.1155/2021/5061570] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
6 Motta R, Cabezas-Camarero S, Torres-Mattos C, Riquelme A, Calle A, Figueroa A, Sotelo MJ. Immunotherapy in microsatellite instability metastatic colorectal cancer: Current status and future perspectives. J Clin Transl Res 2021;7:511-22. [PMID: 34541365] [Reference Citation Analysis]
7 Veziant J, Villéger R, Barnich N, Bonnet M. Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer. Cancers (Basel) 2021;13:2215. [PMID: 34063108 DOI: 10.3390/cancers13092215] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
8 Amadei SS, Notario V. Effects of Normal and Cancer Host Tissues on Microbiota Development, Persistence, and Dynamics. Developmental Biology in Prokaryotes and Lower Eukaryotes 2021. [DOI: 10.1007/978-3-030-77595-7_20] [Reference Citation Analysis]